Institution
Seoul National University
Also known as: Seoul Daehakgyo · 서울대학교 · SNU
- 13running trials
- 8closed trials
- 1researcher
- 279,755publications (OpenAlex)
Researchers
Running trials
Not yet recruiting
Not yet recruiting
Enrolling by invitation
A Study of KITE-363 in Participants With Refractory Autoimmune Diseases
Active, not recruiting
Active, not recruiting
Recruiting
Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCL
Active, not recruiting
Recruiting
A Phase 1, SAD and MAD Study to Evaluate the Safety and Tolerability of FB418
Active, not recruiting
Recruiting
NeoFOL-R Trial (Perioperative Versus Adjuvnat FOLFIRINOX in Resectable Pancreatic Cancer)
Active, not recruiting
Active, not recruiting
Active, not recruiting
A Study of Zenocutuzumab (MCLA-128) in Patients With Solid Tumors Harboring an NRG1 Fusion (eNRGy)
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Dermatomyositis and polymyositis (myositis)2 recruiting
- ALS (motor neurone disease)1 recruiting
- Cervical cancer1 recruiting
- Diffuse large B-cell lymphoma1 recruiting
- Lupus (SLE)1 recruiting
- Pancreatic cancer1 recruiting
- Parkinson disease1 recruiting
- Systemic sclerosis (scleroderma)1 recruiting
Closed trials
Completed
Effects of Transcutaneous Auricular Vagus Nerve Stimulation on Appetite
Terminated
(SYMPHONY) Phase 1/2 Study Targeting EGFR Resistance Mechanisms in NSCLC
Completed
TTX-030 in Combination With Immunotherapy and/or Chemotherapy in Subjects With Advanced Cancers
Terminated
Focused Ultrasound for the Treatment of Pancreatic Cancer - an International Registry
Terminated
Completed
Dose Escalation and Expansion Study of FLX475 Monotherapy and in Combination With Pembrolizumab
Completed
ABO- or HLA- Incompatible LDKT Compared to Waitlist/DDKT in Elderly Patients
Completed
Safety and Efficacy Study Using Gene Therapy for Critical Limb Ischemia
Registry name variants (5)
Trial registries list this institution under these names. Each row is one registry entry: its address and the trials registered under it.
Seoul National University
Seoul, 03080
14 trials
Seoul National University College of Medicine
Seoul, 03080
4 trials
Department of Surgery, Seoul National University College of Medicine
Seoul, 110-744
1 trial
NCT05529940NeoFOL-R Trial (Perioperative Versus Adjuvnat FOLFIRINOX in Resectable Pancreatic Cancer)
Contact: Jin- Young Jang, M.D., PhD.
Seoul National University
Seongnam-si Bundan-gu, Gyeonggi-do 13620
1 trial
Seoul National University, Department of Internal Medicine
Seoul, 03080
1 trial
Conditions
Diseases this institution publishes on or runs trials for.
- Stroke256 works · 0 trials
- Liver and biliary tract cancer197 works · 1 trial
- Obesity176 works · 1 trial
- Lung cancer168 works · 5 trials
- Alzheimer disease161 works · 0 trials
- Type 2 diabetes126 works · 0 trials
- Gastric and oesophageal cancer124 works · 0 trials
- Heart failure111 works · 0 trials
- Chronic kidney disease108 works · 1 trial
- Colorectal cancer105 works · 1 trial
- Atrial fibrillation102 works · 0 trials
- Parkinson disease90 works · 1 trial
- Pancreatic cancer60 works · 4 trials
- Asthma57 works · 0 trials
- Fatty liver disease (MASLD/MASH)55 works · 0 trials
- Mild cognitive impairment54 works · 0 trials
- Osteoarthritis51 works · 1 trial
- Ovarian cancer48 works · 1 trial
- Schizophrenia47 works · 1 trial
- Osteoporosis44 works · 0 trials
- Tuberculosis44 works · 0 trials
- Glioblastoma44 works · 0 trials
- COPD42 works · 0 trials
- Thyroid cancer41 works · 0 trials
- Glaucoma41 works · 0 trials
- Bladder cancer40 works · 2 trials
- Coronary artery disease39 works · 0 trials
- Triple-negative breast cancer39 works · 0 trials
- Insomnia38 works · 0 trials
- Depression33 works · 0 trials
Institution data: ROR 04h9pn542 (CC0-1.0)Updated 15 Nov 2026